Patient analysis software producer BostonGene has received $50m from NEC in the form of a series A investment that will fund hiring and technology development.

IT and network technology producer NEC provided $50m of series A funding for US-based medical analytics software provider BostonGene Corporation yesterday. Founded in 2015, BostonGene produces biomedical software for use with cancer patients. It forms a molecular profile of each patient using genome sequencing technology and calculates the nature of their cancer and state of…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.